CLINICAL RESEARCH INFRASTRUCTURE

临床研究基础设施

基本信息

项目摘要

The Clinical Infrastructure Core is an indispensable component of the SCCOR proposal. It is the unifying link that serves each Project in a very specific manner by providing blood for DNA analysis and assorted biochemistry determinations. Just as importantly, the Clinical Infrastructure Core collects, collates, files and retrieves all clinical data, thereby matching each scientific analysis to key clinical information. Moreover, the Clinical Infrastructure Core is responsible for recruiting patients, controls, and unique families for longitudinal study. It is also responsible for the systematic follow-up of these patients and their families. In reality, this is an enormous task, requiring the multiple interactions with patients, families, physicians, research nurses, scientists, IRBs and administrators. Hundreds of samples will be acquired, stored, retrieved and analyzed. An exceptionally large database of clinical, demographic, angiographic, electrocardiographic and echocardiographic material will be generated and maintained. The group at the Cleveland Clinic has already assembled such an organization on site in the form of GeneBank, GeneQuest, CHARISMA and carotid stenting. We have now several years of experience with these two large and important data repositories, generously maintained by strong institutional support. We have space and a large cadre of research nurses, computers, technicians and some physicians to operate this labor-intensive infrastructure. Over time, its operational aspects have improved, and important new data on genes and coronary artery disease are currently emerging. We now have an opportunity with the SCCOR to expand our research goals and further link our clinical phenotype information in the data banks to the genetic and molecular pathophysiology of coronary artery disease. The Clinical Infrastructure Core is clearly essential to this end. We believe that under the able leadership of Drs. Gary Francis and our many dedicated personnel, that we can leverage our unique experience with GeneBank and GeneQuest to focus on new and tightly integrated SCCOR projects designed to explore and better understand the genetics of thrombosis and resistance to anti-platelet agents.
临床基础设施核心是SCCOR提案不可或缺的组成部分。它是统一的纽带 它以非常具体的方式为每个项目服务,为DNA分析提供血液, 生物化学测定同样重要的是,临床基础设施核心收集、整理、归档和 检索所有临床数据,从而将每个科学分析与关键临床信息相匹配。而且 临床基础设施核心负责招募患者、对照和独特家族, study.它还负责对这些病人及其家属进行系统的跟踪。实际上,这是一个 巨大的任务,需要与患者,家属,医生,研究护士,科学家, IRB和管理员。将采集、储存、检索和分析数百个样本。一个 临床、人口统计学、血管造影、心电图和超声心动图的超大数据库 材料将被生成和保存。克利夫兰诊所的研究小组已经组装了这样一个 组织在现场的形式基因库,基因探索,魅力和颈动脉支架。我们现在已经 这两个大型而重要的数据存储库的多年经验,由 强大的机构支持。我们有空间和大量的研究护士,计算机,技术人员和 一些医生来操作这个劳动密集型的基础设施。随着时间的推移,其业务方面有所改善, 关于基因和冠状动脉疾病的重要新数据正在出现。我们现在有一个 机会与SCCOR扩大我们的研究目标,并进一步联系我们的临床表型信息, 冠状动脉疾病的遗传和分子病理生理学的数据库。临床 基础设施核心显然对实现这一目标至关重要。我们相信在加里博士的领导下 弗朗西斯和我们的许多敬业的工作人员,我们可以利用我们与基因库的独特经验, GeneQuest将专注于新的紧密集成的SCCOR项目,旨在探索和更好地了解 血栓形成和抗血小板药物耐药性的遗传学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY Lee FRANCIS其他文献

GARY Lee FRANCIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY Lee FRANCIS', 18)}}的其他基金

TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES
1 型糖尿病发展的 Trialnet 自然史研究
  • 批准号:
    8166554
  • 财政年份:
    2009
  • 资助金额:
    $ 24.1万
  • 项目类别:
BARRIERS TO EFFECTIVE WEIGHT LOSS IN OVERWEIGHT ADOLESCENTS ENROLLED IN AN IN
参加注册的超重青少年有效减肥的障碍
  • 批准号:
    8166557
  • 财政年份:
    2009
  • 资助金额:
    $ 24.1万
  • 项目类别:
ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABE
口服胰岛素可预防有 1 型糖尿病风险的亲属患糖尿病
  • 批准号:
    8166555
  • 财政年份:
    2009
  • 资助金额:
    $ 24.1万
  • 项目类别:
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES
1 型糖尿病发展的 Trialnet 自然史研究
  • 批准号:
    7950887
  • 财政年份:
    2008
  • 资助金额:
    $ 24.1万
  • 项目类别:
UNDERSTANDING THE BARRIERS IN TREATMENT OF OBESITY IN ADOLESCENTS IN CENTRAL VA-
了解弗吉尼亚州中部青少年肥胖治疗的障碍
  • 批准号:
    7950853
  • 财政年份:
    2008
  • 资助金额:
    $ 24.1万
  • 项目类别:
ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABE
口服胰岛素可预防有 1 型糖尿病风险的亲属患糖尿病
  • 批准号:
    7950888
  • 财政年份:
    2008
  • 资助金额:
    $ 24.1万
  • 项目类别:
BARRIERS TO EFFECTIVE WEIGHT LOSS IN OVERWEIGHT ADOLESCENTS ENROLLED IN AN IN
参加注册的超重青少年有效减肥的障碍
  • 批准号:
    7950891
  • 财政年份:
    2008
  • 资助金额:
    $ 24.1万
  • 项目类别:
CLINICAL RESEARCH INFRASTRUCTURE
临床研究基础设施
  • 批准号:
    7493852
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:
UNDERSTANDING THE BARRIERS IN TREATMENT OF OBESITY IN ADOLESCENTS IN CENTRAL VA-
了解弗吉尼亚州中部青少年肥胖治疗的障碍
  • 批准号:
    7717022
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES
1 型糖尿病发展的 Trialnet 自然史研究
  • 批准号:
    7717064
  • 财政年份:
    2007
  • 资助金额:
    $ 24.1万
  • 项目类别:

相似海外基金

REU Site: Summer Undergraduate Research in Chemistry and Biochemistry at Miami University
REU 网站:迈阿密大学化学与生物化学暑期本科生研究
  • 批准号:
    2349468
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Continuing Grant
REU Site: Research Experiences for Community College Students in Chemistry and Biochemistry at Texas A&M University-Commerce
REU 网站:德克萨斯 A 社区学院化学和生物化学专业学生的研究经验
  • 批准号:
    2349522
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Standard Grant
Supporting Talented, Low-Income Undergraduate and Graduate Students in Chemistry and Biochemistry through Career Explorations, Research Experiences, and Scholarships
通过职业探索、研究经验和奖学金支持化学和生物化学领域有才华的低收入本科生和研究生
  • 批准号:
    2322722
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Standard Grant
Conference: Active Learning Communities in Biochemistry
会议:生物化学主动学习社区
  • 批准号:
    2411535
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Standard Grant
Hydrogen and carbon dioxide biochemistry in the bacterial energy-transducing membrane.
细菌能量转换膜中的氢气和二氧化碳生物化学。
  • 批准号:
    BB/Y004302/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Research Grant
ORCC: The Role of Betaine Lipid Biochemistry in Coral Thermal Tolerance
ORCC:甜菜碱脂质生物化学在珊瑚耐热性中的作用
  • 批准号:
    2307516
  • 财政年份:
    2023
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Continuing Grant
Supporting low-income student success in STEM through community, mentoring, and immersive research in biology and biochemistry
通过生物学和生物化学领域的社区、指导和沉浸式研究,支持低收入学生在 STEM 方面取得成功
  • 批准号:
    2221216
  • 财政年份:
    2023
  • 资助金额:
    $ 24.1万
  • 项目类别:
    Standard Grant
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 24.1万
  • 项目类别:
In vivo 2-photon imaging of retinal biochemistry before and after retinal organoid transplantation
视网膜类器官移植前后视网膜生物化学的体内2光子成像
  • 批准号:
    10643273
  • 财政年份:
    2023
  • 资助金额:
    $ 24.1万
  • 项目类别:
Biochemistry of Platelet Desialylation
血小板脱唾液酸化的生物化学
  • 批准号:
    10833844
  • 财政年份:
    2023
  • 资助金额:
    $ 24.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了